SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-23-142012
Filing Date
2023-05-11
Accepted
2023-05-11 16:09:31
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3/A d478076ds3a.htm S-3/A 431512
2 EX-5.1 d478076dex51.htm EX-5.1 26773
3 EX-23.1 d478076dex231.htm EX-23.1 2123
4 GRAPHIC g478076g0511075759710.jpg GRAPHIC 2537
5 GRAPHIC g478076g11a11.jpg GRAPHIC 35976
6 GRAPHIC g478076g22a22.jpg GRAPHIC 39612
7 GRAPHIC g478076g33a33.jpg GRAPHIC 31324
8 GRAPHIC g478076g44a44.jpg GRAPHIC 38146
9 GRAPHIC g478076g55a55.jpg GRAPHIC 27460
  Complete submission text file 0001193125-23-142012.txt   683403
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-271400 | Film No.: 23911059
SIC: 2836 Biological Products, (No Diagnostic Substances)